Psychedelic Therapy Intelligence

The most complete guide to psychedelic therapy trials

Free access to every recruiting trial, company pipeline tracker, and molecule guide — updated daily from ClinicalTrials.gov. Enter your details to get started.

What are you looking for help with? (select all that apply)

No medical information collected at this stage. By continuing you agree to our Privacy Policy. We'll send you updates when trials open in your state.

Live from ClinicalTrials.gov

Find a psychedelic therapy trial near you

Browse open clinical trials for psilocybin, MDMA, ketamine, ibogaine and more. Filter by condition and location. Free to access, always up to date.

—
Actively recruiting trials
40+
Research sites across the US
5
Compounds in active trials
8
Conditions being studied
Condition
Showing — trials
Psilocybin Phase 3 Recruiting
COMP360 Psilocybin for Treatment-Resistant Depression
COMPASS Pathways
A randomised, double-blind, placebo-controlled Phase 3 study evaluating the efficacy and safety of COMP360 psilocybin therapy in adults with treatment-resistant depression who have not responded to at least two adequate antidepressant treatments.
📍 New York · Boston · San Francisco · Chicago
🔬 Treatment-Resistant Depression
MDMA Phase 3 Recruiting
MDMA-Assisted Therapy for Post-Traumatic Stress Disorder
Lykos Therapeutics
A Phase 3 multi-site study examining MDMA-assisted therapy for adults with moderate to severe PTSD. Participants receive three 8-hour MDMA sessions alongside therapeutic support, with preparation and integration sessions. Veterans and first responders particularly encouraged to apply.
📍 Los Angeles · Washington DC · Austin · Denver
🔬 PTSD, Trauma
Ketamine Phase 2 Recruiting
Ketamine-Assisted Psychotherapy for Major Depressive Disorder
Sunstone Therapies
An open-label Phase 2 study assessing the efficacy of ketamine infusions combined with behavioural activation therapy for adults with treatment-resistant major depressive disorder who have not responded to two or more antidepressants.
📍 Rockville, Maryland
🔬 Major Depressive Disorder
Ibogaine Phase 2 Recruiting
Ibogaine Treatment for Veterans with PTSD and Traumatic Brain Injury
Stanford University / DemeRx
The landmark MISTIC trial examining ibogaine-assisted therapy for veterans with PTSD and mild traumatic brain injury. Previous observational data showed dramatic improvements in PTSD symptoms, cognitive function, and quality of life one month post-treatment.
📍 Stanford, California
🔬 PTSD, Traumatic Brain Injury
↑ Example cards — live data loading...

Psychedelic Drug Development Tracker

Every major company developing psychedelic-assisted therapies, organised by pipeline stage. Updated May 2026.

● Phase 3 — Pivotal Trials
● Phase 2 — Efficacy & Dosing
● Phase 1 — Safety Studies

The Molecule Guide

Plain-English explanations of every compound in active psychedelic therapy research.